Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 14, 2025

Effect of Intensive Blood Pressure Control in Patients with Resistant Hypertension: Insights from the STEP Trial.

View Full Paper
Ask AI
Bookmark
Share

Authors

XDXilan DongJBJingjing BaiQLQianhui Ling

Discussion

Loading...

Member takes

Overview

Analysis reveals intensive BP control reduces cardiovascular risk in patients with resistant hypertension while avoiding adverse events.

Key Points

  • Intensive blood pressure control was associated with a significantly lower risk of primary cardiovascular outcomes in patients with resistant hypertension.
  • The hazard ratio for improved outcomes showed a 64% risk reduction (HR, 0.36) for intensive control versus standard, with a P-value of 0.035.
  • Using data from the STEP trial, patients were assessed for cardiovascular events primarily based on their hypertension status and treatment regimen.
  • Intensive blood pressure control did not increase adverse event rates, implying safe management for patients with resistant hypertension.

Cite This Study

Dong et al. (2025) studied this question.

synapsesocial.com/papers/689fc957e46e096235ce1a5ehttps://doi.org/10.1093/eurjpc/zwaf507
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trial2025
  2. 2A Risk Stratification Model for Predicting Benefits of Intensive Blood Pressure Treatment: Analysis of the Systolic Blood Pressure Intervention Trial2025
  3. 3Evaluating the Renal Implications of Intensive Versus Standard Blood Pressure Control in Chronic Kidney Disease: A Systematic Review of Randomized Trials2025
  4. 4Resistant Hypertension: Pathophysiology, Diagnostic Approaches, and Emerging Therapeutic Strategies2026
  5. 5Effects of intensive blood pressure control on cardio-kidney outcomes by KDIGO risk categories: a Post Hoc analysis of ACCORD-BP and SPRINT trials2026